Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03602079 |
|---|---|
| Brief Title: | Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene |
| First Submitted : | July 6, 2018 |
| First Submitted that Met QC Criteria : | July 25, 2018 |
| First Posted : | July 26, 2018 |
| Last Update Submitted that Met QC Criteria : | July 11, 2022 |
| Last Update Posted : | July 12, 2022 |